Atlas Trials

An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

Clinical trial NCT04185363 · COMPLETED

Trial details

NCT number
NCT04185363
Sponsor
Mirum Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Progressive Familial Intrahepatic Cholestasis (PFIC)
Start date
2020-01-08
Primary completion
2025-04-23
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.